Strategic Investment Facilitates Market Entry in China and Advances Ophthalmic Technology Evolving Ultrasound for Corneal Refractive and Cataract Surgery CHICAGO — Auctus Capital Partners is pleased to announce its role as advisor to ArcScan, Inc., supporting the commercial-stage ophthalmology equipment and ultrasound visualization technology company in securing a strategic equity…
When covering Tropos Technologies and Auctus Capital Partners’ recent support to the electric vehicles manufacturer, Mergermarket turned to Auctus’ CFO Tropos CEO for insights on the transaction…
Auctus Capital Partners is pleased to announce its role as exclusive advisor to Tropos Technolgies, Inc., supporting the leading manufacturer and distributor of all-electric compact utility vehicles (eCUVs) in securing financing to accelerate growth and pursue strategies to capture market share in the rapidly expanding segment. Funding was provided by Walleye Capital.
With large sums of capital sitting on the sidelines, PE firms are writing bigger equity checks whether that’s large market activity or low- to mid-market dealmaking. Auctus Capital Partners’ Shawn Jackson shares more insights in this PE Hub article….
McGuireWoods recently launched The Black Professionals in Private Equity & Finance (BPE) initiative to bring together professionals from across the financial services sector to network, share ideas, and promote change in the industry toward a more diverse and inclusive community. The new series features interviews with Black dealmakers and trailblazers…
What are the greatest tends impacting our clients? As we close out 2020 and wait for the ball to drop on 2021, it’s time for our Year in Review and Year Ahead Forecast. Check out our recap of the year that was and the core themes that will impact business, drive deals, and shape the 2021 landscape.
As we look ahead, how can investment banks evolve to create greater value and enhance client relationships in 2021 and beyond? Here are four trends driving change:
Auctus is pleased to announce its role as exclusive advisor to GoPath Laboratories, providing valuation and strategic advisory services, and supporting the multi-specialty pathology laboratory in securing a senior-secured financing package from Signature Bank. The transaction was led by Auctus and its Vice President Ovais Siddiqui.“The company is well-positioned for continued growth with the rising incidence of infectious diseases — including COVD-19 testing, which GoPath offers with 24-48 hour results — and cancer increasing the demand for innovations in diagnostic techniques that are more precise, accurate, and efficient.”
